v3.26.1
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2026
Jul. 29, 2026
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2026  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q2  
Trading Symbol GENB  
Entity Registrant Name Generate Biomedicines, Inc.  
Entity Central Index Key 0002100782  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   128,352,436
Entity Shell Company false  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Security Exchange Name NASDAQ  
Entity File Number 001-43165  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 83-1630228  
Entity Address, Address Line One 101 South Street, Suite 900  
Entity Address, City or Town Somerville  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02143  
City Area Code 888  
Local Phone Number 469-0055  
Document Quarterly Report true  
Document Transition Report false